Frank Koster

Summary

Country: Germany

Publications

  1. doi request reprint Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition
    Frank Koster
    Department of Gynecology and Obstetrics, University of Lubeck, Lubeck, Germany
    Breast Cancer Res Treat 116:273-9. 2009
  2. ncbi request reprint Cell-specific enhancement of liposomal transfection by steroids in steroid receptor expressing cells
    Frank Koster
    Department of Obstetrics and Gynecology, University of Lubeck, D 23538 Lubeck, Germany
    Int J Mol Med 18:1201-5. 2006
  3. ncbi request reprint Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells
    Martin Kloss
    Department of Obstetrics and Gynecology, University of Lubeck, D 23538 Lubeck, Germany
    Anticancer Res 30:4429-34. 2010
  4. doi request reprint Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]
    Stephan Seitz
    Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany
    Anticancer Drugs 24:150-7. 2013
  5. ncbi request reprint Additive effect of steroids and cholesterol on the liposomal transfection of the breast cancer cell line T-47D
    Frank Koster
    Department of Obstetrics and Gynecology, University of Lubeck, Ratzeburger Allee 160, D 23538 Lubeck, Germany
    Int J Mol Med 14:769-72. 2004
  6. ncbi request reprint Immunohistochemistry of DNA mismatch repair enzyme MSH2 is not correlated with prognostic data from endometrial carcinomas
    Andreas Schröer
    Department of Gynecology and Obstetrics, University of Lubeck, Ratzeburger Allee 160, D 23538 Lubeck, Germany
    Anticancer Res 29:4833-7. 2009

Collaborators

Detail Information

Publications6

  1. doi request reprint Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition
    Frank Koster
    Department of Gynecology and Obstetrics, University of Lubeck, Lubeck, Germany
    Breast Cancer Res Treat 116:273-9. 2009
    ..Our in vitro studies demonstrate that targeting the GHRH receptor may be a therapeutic option which should be evaluated in studies in vivo...
  2. ncbi request reprint Cell-specific enhancement of liposomal transfection by steroids in steroid receptor expressing cells
    Frank Koster
    Department of Obstetrics and Gynecology, University of Lubeck, D 23538 Lubeck, Germany
    Int J Mol Med 18:1201-5. 2006
    ..Liposomal transfection in combination with steroids might be useful for a cell-specific enhancement of gene transfer for example in gynecological malignoma where subgroups are expressing high levels of steroid receptors...
  3. ncbi request reprint Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells
    Martin Kloss
    Department of Obstetrics and Gynecology, University of Lubeck, D 23538 Lubeck, Germany
    Anticancer Res 30:4429-34. 2010
    ..The aim of this study was to obtain further information about the regulation of the aforementioned enzymes by vitamin D, calcidiol and calcitriol in cervical and ovarian cancer...
  4. doi request reprint Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]
    Stephan Seitz
    Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany
    Anticancer Drugs 24:150-7. 2013
    ..This investigation provides information on the mechanism of action and efficacy of this new targeted cytotoxic sst analogue and identifies in this relation the sstr as a favorable therapeutic target in TNBC...
  5. ncbi request reprint Additive effect of steroids and cholesterol on the liposomal transfection of the breast cancer cell line T-47D
    Frank Koster
    Department of Obstetrics and Gynecology, University of Lubeck, Ratzeburger Allee 160, D 23538 Lubeck, Germany
    Int J Mol Med 14:769-72. 2004
    ....
  6. ncbi request reprint Immunohistochemistry of DNA mismatch repair enzyme MSH2 is not correlated with prognostic data from endometrial carcinomas
    Andreas Schröer
    Department of Gynecology and Obstetrics, University of Lubeck, Ratzeburger Allee 160, D 23538 Lubeck, Germany
    Anticancer Res 29:4833-7. 2009
    ..Insufficient MMR activity or expression levels could be prognostic markers of the disease...